Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Anemia 7Colorectal Neoplasms 4Anemia, Iron-Deficiency 4Postoperative Complications 3Neoplasms 3Adenocarcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Plexosarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Liver Neoplasms 1Inflammatory Breast Neoplasms 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Cancer Anaemia 1Aortic Aneurysm 1Advanced Gastric Carcinoma 1

Interventions

Oxaliplatin 200Capecitabine 116S 1 (combination) 106Fluorouracil 105Docetaxel 100Cisplatin 88Leucovorin 75Paclitaxel 71Irinotecan 68apatinib 43sintilimab 42Drug Therapy 42Surgical Procedures, Operative 37Hyperthermic Intraperitoneal Chemotherapy 34pembrolizumab 32Radiotherapy 31Trastuzumab 30Gastrectomy 23Nivolumab 22Epirubicin 22Tegafur 21Bevacizumab 21XELOX 20titanium silicide 19camrelizumab 19tislelizumab 17Ramucirumab 17Carboplatin 16Neoadjuvant Therapy 15Endoscopic Mucosal Resection 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Stomach Neoplasms × ferric carboxymaltose × Clear all
NCT04168346 2019-11-19

IRONSTOMACH

Helsinki University Central Hospital

Phase 4 Not yet recruiting
202 enrolled
Classical hematologyGastrointestinal

Anemia, Stomach Neoplasms, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡